Bigul

Concord Drugs Ltd - 538965 - Board Meeting Intimation for Postponement Of Board Meeting To 14.02.2019

Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of Concord Drugs Limited scheduled to be held Wednesday, 13.02.2019 has been deferred to Thursday, 14.02.2019 at 5:00 p.m. at the registered office of the company for consideration of un-audited results for the quarter ended 31.12.2018 and any other matter with the permission of the chair
13-02-2019
Bigul

Concord Drugs Ltd - 538965 - Closure of Trading Window

Closure of Trading Window for the un-audited financial results for the quarter ended 31.12.2018
24-01-2019
Bigul

Concord Drugs Ltd - 538965 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31.12.2018

Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve Un-audited financial results for the quarter ended 31.12.2018
24-01-2019
Bigul

Concord Drugs Ltd - 538965 - Shareholding for the Period Ended December 31, 2018

Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
21-01-2019
Bigul

Concord Drugs Ltd - 538965 - Statement Of Investor Complaints For The Quarter Ended December 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr. Nagi ReddyDesignation :- Director
10-01-2019
Bigul

Un-Audited Financial Results For The Quarter Ended 30.09.2018

Un-audited financial results for the quarter ended 30.09.2018
14-11-2018
Bigul

Closure of Trading Window

Closure of trading window
05-11-2018
Bigul

Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30.09.2018

CONCORD DRUGS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.09.2018
05-11-2018
Bigul

Compliance Certificate (RTA & Compliance Officer)

Compliance certificate (RTA & Compliance Officer)
30-10-2018
Bigul

PCS Certificate For Transfer/Transmission/Transposition

PCS Certificate for Transfer/Transmission/Transposition
30-10-2018
Next Page
Close

Let's Open Free Demat Account